Literature DB >> 30223114

An in-depth characterization of a large cohort of adult patients with eosinophilic esophagitis.

Lyvia Y Leigh1, Jonathan M Spergel2.   

Abstract

BACKGROUND: Eosinophilic esophagitis (EoE) is a chronic, allergic, immune-mediated disease associated with increased risk of comorbid atopic conditions.
OBJECTIVE: To perform an in-depth characterization of a large cohort of manually verified adult patients with EoE, including evaluation of less studied associations, such as pollen food allergy syndrome, anaphylaxis, autoimmunity, and psychiatric comorbidities.
METHODS: We performed a manual retrospective electronic medical record review of 1,218 patients with EoE identified by International Classification of Diseases, Ninth Revision and International Classification of Disease, 10th Revision codes from the University of Pennsylvania Health Systems. Through manual medical record review, we evaluated patient demographics, family and smoking history, laboratory and endoscopic findings, treatment, and comorbid atopic, autoimmune, and psychiatric conditions.
RESULTS: A total of 950 of the 1,218 patients had biopsy-proven EoE. This cohort was predominantly male, white, and never-smokers who presented most commonly with dysphagia, with an initial biopsy results showing 49 eosinophils per high-powered field, a serum absolute eosinophilic count of 446,000/µL, and mean total IgE level of 243 IU/mL. Of the patients, 55% had impaction (of which 38% required endoscopic removal), and 56% had strictures or fibrosis (of which 56% underwent dilatation). Therapy used was predominantly (77%) medical only. Comorbid atopy, pollen food allergy syndrome, drug allergy, anaphylaxis, autoimmunity, and psychiatric illnesses were higher in the EoE cohort compared with the general University of Pennsylvania Health Systems population.
CONCLUSION: Our adult cohort of manually verified, biopsy-proven EoE had an increased risk of pollen food allergy syndrome, anaphylaxis, and comorbid autoimmune and psychiatric conditions compared with the University of Pennsylvania Health Systems population. There was also an increased prevalence of impaction and stricture or fibrosis requiring endoscopic intervention compared with the pediatric population.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30223114     DOI: 10.1016/j.anai.2018.09.452

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  10 in total

1.  Screening children for eosinophilic esophagitis: allergic and other risk factors.

Authors:  Melanie A Ruffner; Peter Capucilli; David A Hill; Jonathan M Spergel
Journal:  Expert Rev Clin Immunol       Date:  2019-02-20       Impact factor: 4.473

Review 2.  The Use of Electronic Health Records to Study Drug-Induced Hypersensitivity Reactions from 2000 to 2021: A Systematic Review.

Authors:  Fatima Bassir; Sheril Varghese; Liqin Wang; Yen Po Chin; Li Zhou
Journal:  Immunol Allergy Clin North Am       Date:  2022-03-31       Impact factor: 3.152

3.  Medical algorithm: Diagnosis and treatment of eosinophilic esophagitis in children.

Authors:  Jonathan M Spergel; Terri A Brown-Whitehorn; Amanda Muir; Chris A Liacouras
Journal:  Allergy       Date:  2020-01-31       Impact factor: 13.146

Review 4.  Anxiety and Depression in Eosinophilic Esophagitis: A Scoping Review and Recommendations for Future Research.

Authors:  Tiffany H Taft; Livia Guadagnoli; Emily Edlynn
Journal:  J Asthma Allergy       Date:  2019-12-09

Review 5.  Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions.

Authors:  Alfred D Doyle; Mia Y Masuda; Hirohito Kita; Benjamin L Wright
Journal:  Front Immunol       Date:  2020-12-01       Impact factor: 7.561

6.  Validation of the diagnosis of eosinophilic esophagitis based on histopathology reports in Sweden.

Authors:  Lovisa Röjler; Ida Glimberg; Marjorie M Walker; John J Garber; Jonas F Ludvigsson
Journal:  Ups J Med Sci       Date:  2021-08-13       Impact factor: 2.384

7.  Eosinophilic oesophagitis in Denmark: Population-based incidence and prevalence in a nationwide study from 2008 to 2018.

Authors:  Kristine Højgaard Allin; Gry Poulsen; Dorte Melgaard; Line Tegtmeier Frandsen; Tine Jess; Anne Lund Krarup
Journal:  United European Gastroenterol J       Date:  2022-09-15       Impact factor: 6.866

8.  The Risk of Esophageal Food Impaction in Eosinophilic Esophagitis Patients: The Role of Clinical and Socioeconomic Factors.

Authors:  Tarik Alhmoud; Sami Ghazaleh; Marcel Ghanim; Roberta E Redfern
Journal:  Clin Exp Gastroenterol       Date:  2022-09-15

9.  Pediatric eosinophilic esophagitis outcomes vary with co-morbid eczema and pollen food syndrome.

Authors:  Julia Sessions; Natasha Purington; Yiwen Wang; Sean McGhee; Sayantani Sindher; Alka Goyal; Nasim Khavari
Journal:  Front Allergy       Date:  2022-09-02

Review 10.  The Gut-Immune-Brain Axis in Autism Spectrum Disorders; A Focus on Amino Acids.

Authors:  Joris H J van Sadelhoff; Paula Perez Pardo; Jiangbo Wu; Johan Garssen; Jeroen van Bergenhenegouwen; Astrid Hogenkamp; Anita Hartog; Aletta D Kraneveld
Journal:  Front Endocrinol (Lausanne)       Date:  2019-04-16       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.